In contrast, reduced expression of TRIM29 was noted in breast and prostate cancers [10], [11] and evidence for growth inhibition and tumor suppression was demonstrated in breast non-malignant and malignant cell lines [12]. Here, TRIM29 is linked to neoplasm.